ICAM1 and dry eye syndrome: A mouse desiccating dry eye model showed beneficial effects by blocking the interaction between LFA-1 (Lymphocyte function-associated antigen 1; CD11a) and ICAM-1 (Intercellular Adhesion Molecule 1; CD54).